Dose modification and dose intensity during treatment with pirfenidone: analysis of pooled data from three multinational phase III trials
Sign Up to like & getrecommendations! Published in 2018 at "BMJ Open Respiratory Research"
DOI: 10.1136/bmjresp-2018-000323
Abstract: Introduction Temporary dose modifications, such as reductions or interruptions, may allow patients to better manage adverse events (AEs) associated with pirfenidone use and continue treatment for idiopathic pulmonary fibrosis (IPF). However, the impact of such… read more here.
Keywords: analysis; treatment; treatment pirfenidone; dose intensity ... See more keywords